BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37478521)

  • 1. Diagnostic algorithm for challenging blue cell sinonasal carcinoma.
    Laforga JB; Abdullah B
    Pathol Res Pract; 2023 Aug; 248():154683. PubMed ID: 37478521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022: SWI/SNF-deficient Sinonasal Neoplasms: An Overview.
    Agaimy A
    Head Neck Pathol; 2022 Mar; 16(1):168-178. PubMed ID: 35307773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SMARCA4-deficient Sinonasal Carcinoma.
    Agaimy A; Weichert W
    Head Neck Pathol; 2017 Dec; 11(4):541-545. PubMed ID: 28176137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity.
    Agaimy A; Hartmann A; Antonescu CR; Chiosea SI; El-Mofty SK; Geddert H; Iro H; Lewis JS; Märkl B; Mills SE; Riener MO; Robertson T; Sandison A; Semrau S; Simpson RH; Stelow E; Westra WH; Bishop JA
    Am J Surg Pathol; 2017 Apr; 41(4):458-471. PubMed ID: 28291122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent Loss of SMARCA4 in Sinonasal Teratocarcinosarcoma.
    Rooper LM; Uddin N; Gagan J; Brosens LAA; Magliocca KR; Edgar MA; Thompson LDR; Agaimy A; Bishop JA
    Am J Surg Pathol; 2020 Oct; 44(10):1331-1339. PubMed ID: 32520761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SWI/SNF-deficient Sinonasal Carcinomas.
    Agaimy A
    Adv Anat Pathol; 2023 Mar; 30(2):95-103. PubMed ID: 36580412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMARCA4/BRG1-Deficient Sinonasal Carcinoma.
    Kakkar A; Ashraf SF; Rathor A; Adhya AK; Mani S; Sikka K; Jain D
    Arch Pathol Lab Med; 2022 Sep; 146(9):1122-1130. PubMed ID: 34871352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SMARCA4-deficient Sinonasal Carcinoma: A Series of 10 Cases Expanding the Genetic Spectrum of SWI/SNF-driven Sinonasal Malignancies.
    Agaimy A; Jain D; Uddin N; Rooper LM; Bishop JA
    Am J Surg Pathol; 2020 May; 44(5):703-710. PubMed ID: 31934917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. INI-1 (SMARCB1)-Deficient Undifferentiated Sinonasal Carcinoma: Novel Paradigm of Molecular Testing in the Diagnosis and Management of Sinonasal Malignancies.
    Shaverdashvili K; Azimi-Nekoo E; Cohen P; Akbar N; Ow TJ; Halmos B; Castellucci E
    Oncologist; 2020 Sep; 25(9):738-744. PubMed ID: 32337786
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Laforga JB; Abdullah B
    Indian J Otolaryngol Head Neck Surg; 2023 Dec; 75(4):3866-3870. PubMed ID: 37974682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recently described neoplasms of the sinonasal tract.
    Bishop JA
    Semin Diagn Pathol; 2016 Mar; 33(2):62-70. PubMed ID: 26776744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Grade Sinonasal Carcinoma: Classification Through Molecular Profiling.
    Guilmette J; Sadow PM
    Arch Pathol Lab Med; 2019 Nov; 143(11):1416-1419. PubMed ID: 30779592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. INI1 (SMARCB1)-Deficient Sinonasal Carcinoma: A Clinicopathologic Report of 2 Cases.
    Wasserman JK; Dickson BC; Perez-Ordonez B; de Almeida JR; Irish JC; Weinreb I
    Head Neck Pathol; 2017 Jun; 11(2):256-261. PubMed ID: 27644951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sinonasal neoplasms: Update from the WHO 2022].
    Agaimy A
    Pathologie (Heidelb); 2023 Jul; 44(4):233-239. PubMed ID: 37286851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMARCB1 (INI1)-Deficient Sinonasal Carcinoma with Yolk Sac differentiation Showing Co-loss of SMARCA4 Immunostaining - A Case Report and Literature Review.
    Ng JKM; Chan JYK; Li JJX; Tang K; Yeung DCM; Chan ABW
    Head Neck Pathol; 2022 Sep; 16(3):934-941. PubMed ID: 35257325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Molecular Profiling of Sinonasal Teratocarcinosarcoma Highlights Recurrent SMARCA4 Inactivation and CTNNB1 Mutations.
    Rooper LM; Agaimy A; Gagan J; Simpson RHW; Thompson LDR; Trzcinska AM; Ud Din N; Bishop JA
    Am J Surg Pathol; 2023 Feb; 47(2):224-233. PubMed ID: 36206446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NUT midline carcinomas of the sinonasal tract.
    Bishop JA; Westra WH
    Am J Surg Pathol; 2012 Aug; 36(8):1216-21. PubMed ID: 22534723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Utility of NUT gene expression and rearrangement in diagnosis of NUT midline carcinoma in upper respiratory tract].
    Fang W; French CA; Cameron MJ; Han YD; Liu HG
    Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):519-24. PubMed ID: 23157742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine needle aspiration cytology of metastatic SMARCA4-deficient sinonasal teratocarcinosarcoma: First report in literature.
    Gopakumar A; Kakkar A; Kaur K; Sikka K; Thakar A; Sharma A; Jain D
    Diagn Cytopathol; 2023 Apr; 51(4):E129-E136. PubMed ID: 36680532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical management of emerging sinonasal malignancies.
    Contrera KJ; Woody NM; Rahman M; Sindwani R; Burkey BB
    Head Neck; 2020 Aug; 42(8):2202-2212. PubMed ID: 32212360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.